BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 19414812)

  • 1. Antigen-specific blockade of lethal CD8 T-cell mediated autoimmunity in a mouse model of multiple sclerosis.
    Na SY; Eujen H; Göbel K; Meuth SG; Martens K; Wiendl H; Hünig T
    J Immunol; 2009 May; 182(10):6569-75. PubMed ID: 19414812
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Naive CD8 T-cells initiate spontaneous autoimmunity to a sequestered model antigen of the central nervous system.
    Na SY; Cao Y; Toben C; Nitschke L; Stadelmann C; Gold R; Schimpl A; Hünig T
    Brain; 2008 Sep; 131(Pt 9):2353-65. PubMed ID: 18669487
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exposure to IL-15 and IL-21 enables autoreactive CD8 T cells to respond to weak antigens and cause disease in a mouse model of autoimmune diabetes.
    Ramanathan S; Dubois S; Chen XL; Leblanc C; Ohashi PS; Ilangumaran S
    J Immunol; 2011 May; 186(9):5131-41. PubMed ID: 21430227
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Peptide-activated double-negative T cells can prevent autoimmune type-1 diabetes development.
    Ford MS; Chen W; Wong S; Li C; Vanama R; Elford AR; Asa SL; Ohashi PS; Zhang L
    Eur J Immunol; 2007 Aug; 37(8):2234-41. PubMed ID: 17578845
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD8(+) T cells specific for beta cells encounter their cognate antigens in the islets of NOD mice.
    Pang S; Zhang L; Wang H; Yi Z; Li L; Gao L; Zhao J; Tisch R; Katz JD; Wang B
    Eur J Immunol; 2009 Oct; 39(10):2716-24. PubMed ID: 19658094
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased antigen cross-presentation but impaired cross-priming after activation of peroxisome proliferator-activated receptor gamma is mediated by up-regulation of B7H1.
    Klotz L; Hucke S; Thimm D; Classen S; Gaarz A; Schultze J; Edenhofer F; Kurts C; Klockgether T; Limmer A; Knolle P; Burgdorf S
    J Immunol; 2009 Jul; 183(1):129-36. PubMed ID: 19535643
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oligodendrocytes enforce immune tolerance of the uninfected brain by purging the peripheral repertoire of autoreactive CD8+ T cells.
    Na SY; Hermann A; Sanchez-Ruiz M; Storch A; Deckert M; Hünig T
    Immunity; 2012 Jul; 37(1):134-46. PubMed ID: 22683122
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Abortive activation precedes functional deletion of CD8+ T cells following encounter with self-antigens expressed by resting B cells in vivo.
    Fraser JM; Janicki CN; Raveney BJ; Morgan DJ
    Immunology; 2006 Sep; 119(1):126-33. PubMed ID: 16796693
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Induction of experimental autoimmune encephalomyelitis in transgenic mice expressing ovalbumin in oligodendrocytes.
    Cao Y; Toben C; Na SY; Stark K; Nitschke L; Peterson A; Gold R; Schimpl A; Hünig T
    Eur J Immunol; 2006 Jan; 36(1):207-15. PubMed ID: 16342234
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Maintaining or breaking CD8+ T-cell tolerance to beta islet cell antigens: lessons from transgenic mouse models.
    Piaggio E; Hartemann-Heurtier A; Cabarrocas J; Desbois S; Mars LT; Zappulla JP; Liblau RS
    J Autoimmun; 2004 Mar; 22(2):115-20. PubMed ID: 14987739
    [No Abstract]   [Full Text] [Related]  

  • 11. A transgenic mouse model for T-cell ignorance of a glial autoantigen.
    Cabarrocas J; Piaggio E; Zappulla JP; Desbois S; Mars LT; Lassmann H; Liblau RS
    J Autoimmun; 2004 May; 22(3):179-89. PubMed ID: 15041038
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mast cell-mediated antigen presentation regulates CD8+ T cell effector functions.
    Stelekati E; Bahri R; D'Orlando O; Orinska Z; Mittrücker HW; Langenhaun R; Glatzel M; Bollinger A; Paus R; Bulfone-Paus S
    Immunity; 2009 Oct; 31(4):665-76. PubMed ID: 19818652
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Autoreactive T cells in multiple sclerosis.
    Zhang J; Weiner HL; Hafler DA
    Int Rev Immunol; 1992; 9(3):183-201. PubMed ID: 1285060
    [No Abstract]   [Full Text] [Related]  

  • 14. Autoreactive CD8+ T cells in multiple sclerosis: a new target for therapy?
    Friese MA; Fugger L
    Brain; 2005 Aug; 128(Pt 8):1747-63. PubMed ID: 15975943
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The duration of TCR/pMHC interactions regulates CTL effector function and tumor-killing capacity.
    Riquelme E; Carreño LJ; González PA; Kalergis AM
    Eur J Immunol; 2009 Aug; 39(8):2259-69. PubMed ID: 19637198
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clonal expansions of pathogenic CD8+ effector cells in the CNS of myelin mutant mice.
    Leder C; Schwab N; Ip CW; Kroner A; Nave KA; Dornmair K; Martini R; Wiendl H
    Mol Cell Neurosci; 2007 Nov; 36(3):416-24. PubMed ID: 17889554
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multiple sclerosis: MHC associations and therapeutic implications.
    Holmes S; Friese MA; Siebold C; Jones EY; Bell J; Fugger L
    Expert Rev Mol Med; 2005 Feb; 7(3):1-17. PubMed ID: 15710050
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Degenerate T-cell receptor recognition, autoreactive cells, and the autoimmune response in multiple sclerosis.
    Markovic-Plese S
    Neuroscientist; 2009 Jun; 15(3):225-31. PubMed ID: 19297658
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IL-15 is critical for the maintenance and innate functions of self-specific CD8(+) T cells.
    Itsumi M; Yoshikai Y; Yamada H
    Eur J Immunol; 2009 Jul; 39(7):1784-93. PubMed ID: 19544306
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Control of autoimmunity by "epitope theft".
    Kranc KR; Taylor AM; Willcox N; Fugger L
    Trends Mol Med; 2005 Jan; 11(1):1-4. PubMed ID: 15649815
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.